HNN3.0
Register
Register
Register

Project cooperationUpdated on 21 January 2026

High-Volume Clinical Center for Cardiovascular Research & Innovation (IKVBD)

Medical Doctor - Center of Excellence at Institute for Cardiovascular Diseases "Dedinje" - IKVBD

Belgrade, Serbia

About

The Institute for Cardiovascular Diseases Dedinje (IKVBD) is a premier, high-volume cardiovascular center specializing in the full spectrum of modern cardiovascular medicine and surgery. As a leading institution in the region, we provide a robust clinical environment for cutting-edge research and the scaling of healthcare innovations.

We are seeking to join consortia as a clinical partner for the Horizon Europe 2026 Cluster Health calls.

Our Contribution:

  • Clinical Expertise: Access to a multidisciplinary team of world-class cardiologists, cardiac surgeons, and vascular surgeons with expertise in complex interventions and long-term patient management.

  • Research Capacity: An established infrastructure for clinical research, including experienced investigators and dedicated teams capable of managing high-quality data collection.

  • High-Volume Validation Site: As a high-capacity hospital, we offer an ideal environment for the clinical validation of new technologies, digital health solutions, and innovative therapeutic pathways.

  • Patient Cohorts: Access to large, diverse patient populations, which is essential for investigating sex and gender-disaggregated data, risk factors, and disease determinants.

  • Implementation & Scalability: Expert insight into clinical workflows and the practical requirements for scaling medical innovations within a high-pressure hospital setting.

IKVBD is committed to advancing cardiovascular health through international collaboration, providing the clinical grounding and expertise necessary to translate research into scalable real-world impact.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
  • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)

Type

  • Partner seeks Consortium/Coordinator

Similar opportunities

  • Project cooperation

    AI-driven Telemedicine and Hypertension Research for Cardiovascular Health (Horizon Europe Partnerships)

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Ramūnas Ragauskas

    Head of Sales at UAB Synergy Effect

    Vilnius, Lithuania

  • Project cooperation

    Early detection of heart failure in metabolic and high-risk cardiovascular diseases

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Slavica Mitrovska

    Cardiologist at Polyclinic Biotek

    Skopje, North Macedonia

  • Project cooperation

    Digital Health and Real-World Evidence for Advancing and Scaling Cardiovascular Innovation

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Konstantina Koutsiara

    Project Manager at VIDAVO S.A.

    Thessaloniki, Greece